MyHealthTeams Co-founders Eric Peacock and Mary Ray
MyHealthTeams, a San Francisco, CA-based creator of the largest and fastest-growing social networks for people facing chronic health conditions raised $9.44 million in a Series B financing round led by strategic investor UCB, a global biopharmaceutical company. This financing brings total investment in MyHealthTeams to $26.84M, building on the company's Seed and Series A1, A2 and A3 rounds. Existing investors including Adams Street Partners,
Read More
Cedars-Sinai Research: Patients Using On-Demand VR Reduces Pain Scores
Cedars-Sinai researchers reveal hospitalized patients on-demand use of virtual reality (VR) resulted in statistically significant improvements in pain
Your browser does not support HTML5 video.
A new study led by Cedars-Sinai's Health Service Research, published in PLOS|ONE, the Public Library of Science, demonstrates the effectiveness of using therapeutic virtual reality (VR) to
Read More
Mayo Clinic Backs Imago Systems to “Re-Visualize” The Mammogram for Breast Cancer Detection
Mayo Clinic has signed a know-how license agreement with Imago Systems, a medical imaging company with an advanced machine learning software that is designed to dramatically improve a clinician’s ability to detect cancer and other abnormalities earlier and more accurately. Imago Pilot DetailsAs part of the know-how license agreement, a breast imaging research specialist at Mayo Clinic will spearhead Imago's pilot and pivotal studies to clinically validate Imago's visual intelligence software as
Read More
FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)
Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More
What’s AI’s Holdup in Healthcare? The Answer Is In The Cloud
Fabien Beckers, Ph.D., CEO, Arterys
When you consider what technology has the most potential to transform healthcare over the next decade and beyond, no doubt your first thoughts turn to artificial intelligence (AI), machine learning (ML) and deep learning (DL). Already these technologies are showing promise in helping clinicians work faster and smarter, identifying trends, alerting us to signs that can predict and prevent diseases, and providing insights into potential treatments and
Read More
Pittsburgh Health Data Alliance, Amazon Partner on Machine Learning Research Sponsorship
Pittsburgh Health Data Alliance (PHDA) announced today that it is working closely with Amazon Web Services (AWS), an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.Leveraging Machine Learning to Power Medical ResearchA unique consortium formed four years ago by UPMC, the University of Pittsburgh and Carnegie Mellon University (CMU), the PHDA uses
Read More
SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals
SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will
Read More
Ethical Concerns of AI in Healthcare: Can AI Do More Harm Than Good?
Tim Casey, Director of the STEPPS Program at California Western School of Law
The AI doctor can see you now, but it shouldn't treat you until ethics are in place. Professor Timothy Casey explains.
Artificial Intelligence (AI) and ethics—once mythical adversaries only on-screen like in “The Terminator” circa 1984— are now actually at virtual odds in 2019. This time, there are no catchy slogans like Arnold Schwarzenegger’s “I’ll be back,” but the moral question has returned:
Does AI’s
Read More
Backed by Mayo Clinic Study, Eko Launches Cardiac Remote Monitoring App, Eko Home
Currently being used in a study by Mayo Clinic, cardiac monitoring app Eko Home enhances outpatient cardiac data collection and demonstrates real world efficacyEko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced its cardiac remote monitoring app, Eko Home. The app is a first-of-its-kind service that enables precise remote monitoring of cardiac function using ECG and heart sounds. Eko Home can be used to create drug-data
Read More
Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)
Syapse, a San Francisco, CA-based precision medicine company, today announced that it has entered into a strategic collaboration with Pfizer to advance cancer outcomes research using real-world evidence (RWE) toward the ultimate goal of improving patient health. This collaboration will initially focus on the molecular testing and therapy choices on precision oncology journeys in the healthcare system setting.Syapse NetworkThe Syapse Network enables health systems and their providers to learn
Read More